Members |
acceptabilityId |
150 minute plasma prolactin level |
Acceptable (foundation metadata concept) |
150 minute plasma prolactin level |
Preferred (foundation metadata concept) |
150 minute plasma prolactin level |
Preferred (foundation metadata concept) |
150 minute plasma prolactin level (procedure) |
Preferred (foundation metadata concept) |
150 minute plasma prolactin level (procedure) |
Preferred (foundation metadata concept) |
150 minute plasma prolactin measurement |
Preferred (foundation metadata concept) |
150 minute plasma prolactin measurement (procedure) |
Preferred (foundation metadata concept) |
150 minute serum FSH level |
Preferred (foundation metadata concept) |
150 minute serum FSH level |
Acceptable (foundation metadata concept) |
150 minute serum FSH level |
Preferred (foundation metadata concept) |
150 minute serum FSH level (procedure) |
Preferred (foundation metadata concept) |
150 minute serum FSH level (procedure) |
Preferred (foundation metadata concept) |
150 minute serum FSH measurement |
Preferred (foundation metadata concept) |
150 minute serum GH level |
Preferred (foundation metadata concept) |
150 minute serum GH level |
Preferred (foundation metadata concept) |
150 minute serum GH level |
Acceptable (foundation metadata concept) |
150 minute serum GH level (procedure) |
Preferred (foundation metadata concept) |
150 minute serum GH level (procedure) |
Preferred (foundation metadata concept) |
150 minute serum GH measurement |
Preferred (foundation metadata concept) |
150 minute serum LH level |
Acceptable (foundation metadata concept) |
150 minute serum LH level |
Preferred (foundation metadata concept) |
150 minute serum LH level |
Preferred (foundation metadata concept) |
150 minute serum LH level (procedure) |
Preferred (foundation metadata concept) |
150 minute serum LH level (procedure) |
Preferred (foundation metadata concept) |
150 minute serum LH measurement |
Preferred (foundation metadata concept) |
150 minute serum TSH level |
Preferred (foundation metadata concept) |
150 minute serum TSH level |
Preferred (foundation metadata concept) |
150 minute serum TSH level |
Acceptable (foundation metadata concept) |
150 minute serum TSH level (procedure) |
Preferred (foundation metadata concept) |
150 minute serum TSH level (procedure) |
Preferred (foundation metadata concept) |
150 minute serum TSH measurement |
Acceptable (foundation metadata concept) |
150 minute serum cortisol level |
Acceptable (foundation metadata concept) |
150 minute serum cortisol level |
Preferred (foundation metadata concept) |
150 minute serum cortisol level |
Preferred (foundation metadata concept) |
150 minute serum cortisol level (procedure) |
Preferred (foundation metadata concept) |
150 minute serum cortisol level (procedure) |
Preferred (foundation metadata concept) |
150 minute serum cortisol measurement |
Preferred (foundation metadata concept) |
150 minute serum cortisol measurement (procedure) |
Preferred (foundation metadata concept) |
150 minute serum follicle stimulating hormone measurement |
Acceptable (foundation metadata concept) |
150 minute serum follicle stimulating hormone measurement (procedure) |
Preferred (foundation metadata concept) |
150 minute serum glucose level |
Preferred (foundation metadata concept) |
150 minute serum glucose level |
Acceptable (foundation metadata concept) |
150 minute serum glucose level |
Preferred (foundation metadata concept) |
150 minute serum glucose level (procedure) |
Preferred (foundation metadata concept) |
150 minute serum glucose level (procedure) |
Preferred (foundation metadata concept) |
150 minute serum glucose measurement |
Preferred (foundation metadata concept) |
150 minute serum glucose measurement (procedure) |
Preferred (foundation metadata concept) |
150 minute serum growth hormone measurement |
Acceptable (foundation metadata concept) |
150 minute serum growth hormone measurement (procedure) |
Preferred (foundation metadata concept) |
150 minute serum luteinising hormone measurement |
Acceptable (foundation metadata concept) |
150 minute serum luteinizing hormone measurement (procedure) |
Preferred (foundation metadata concept) |
150 minute serum prolactin level |
Acceptable (foundation metadata concept) |
150 minute serum prolactin level |
Preferred (foundation metadata concept) |
150 minute serum prolactin level |
Preferred (foundation metadata concept) |
150 minute serum prolactin level (procedure) |
Preferred (foundation metadata concept) |
150 minute serum prolactin level (procedure) |
Preferred (foundation metadata concept) |
150 minute serum prolactin measurement |
Preferred (foundation metadata concept) |
150 minute serum prolactin measurement (procedure) |
Preferred (foundation metadata concept) |
150-Gd |
Acceptable (foundation metadata concept) |
1500 |
Preferred (foundation metadata concept) |
1500 (qualifier value) |
Preferred (foundation metadata concept) |
15000 |
Preferred (foundation metadata concept) |
15000 (qualifier value) |
Preferred (foundation metadata concept) |
150000 |
Preferred (foundation metadata concept) |
150000 (qualifier value) |
Preferred (foundation metadata concept) |
1500000 |
Preferred (foundation metadata concept) |
1500000 (qualifier value) |
Preferred (foundation metadata concept) |
15000000 |
Preferred (foundation metadata concept) |
15000000 (qualifier value) |
Preferred (foundation metadata concept) |
151-Gd |
Acceptable (foundation metadata concept) |
152-Gd |
Acceptable (foundation metadata concept) |
152.4 |
Preferred (foundation metadata concept) |
152.4 (qualifier value) |
Preferred (foundation metadata concept) |
153-Gd |
Acceptable (foundation metadata concept) |
153-Sm |
Acceptable (foundation metadata concept) |
1537 U |
Preferred (foundation metadata concept) |
154 |
Preferred (foundation metadata concept) |
154 (qualifier value) |
Preferred (foundation metadata concept) |
15885 |
Preferred (foundation metadata concept) |
15885 (qualifier value) |
Preferred (foundation metadata concept) |
159-Gd |
Acceptable (foundation metadata concept) |
15Fr |
Acceptable (foundation metadata concept) |
15M pre dose ornithine |
Acceptable (foundation metadata concept) |
15q overgrowth syndrome |
Preferred (foundation metadata concept) |
15q overgrowth syndrome (disorder) |
Preferred (foundation metadata concept) |
15q partial monosomy syndrome |
Preferred (foundation metadata concept) |
15q partial monosomy syndrome (disorder) |
Preferred (foundation metadata concept) |
15q partial trisomy syndrome |
Preferred (foundation metadata concept) |
15q partial trisomy syndrome (disorder) |
Preferred (foundation metadata concept) |
15q11.2 microdeletion syndrome |
Preferred (foundation metadata concept) |
15q11.2 microdeletion syndrome (disorder) |
Preferred (foundation metadata concept) |
15q11.2 microdeletion syndrome is a rare partial autosomal monosomy with a variable phenotypic expression and reduced penetrance associated with an increased susceptibility to neuropsychiatric or neurodevelopmental disorders including delayed psychomotor development, speech delay, autism spectrum disorder, attention deficit-hyperactivity disorder, obsessive-compulsive disorder, epilepsy or seizures. It may also include mild non-specific dysmorphic features (such as dysplastic ears, broad forehead, hypertelorism), cleft palate, neurological and neuroimaging abnormalities (such as ataxia and muscular hypotonia). |
Preferred (foundation metadata concept) |
15q11q13 microduplication syndrome |
Preferred (foundation metadata concept) |
15q11q13 microduplication syndrome (disorder) |
Preferred (foundation metadata concept) |
15q13.3 deletion syndrome |
Acceptable (foundation metadata concept) |
15q13.3 microdeletion |
Preferred (foundation metadata concept) |
15q13.3 microduplication syndrome |
Preferred (foundation metadata concept) |
15q13.3 microduplication syndrome (disorder) |
Preferred (foundation metadata concept) |
15q14 microdeletion syndrome |
Preferred (foundation metadata concept) |
15q14 microdeletion syndrome (disorder) |
Preferred (foundation metadata concept) |
15q14 microdeletion syndrome is a recently described syndrome characterised by developmental delay, short stature and facial dysmorphism. |
Preferred (foundation metadata concept) |